Oncopeptides AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2018-08-14 | Oncopeptides AB | Claes Wenthzel | Annan befattningshavare | Acquisition | 10 000 | 154 | SEK | 1 540 000 | 2018-08-13 |
| 2018-08-05 | Oncopeptides AB | Eva Sabina Marianne Nordström | Vice VD | Acquisition | 151 200 | 0,11 | SEK | 16 632 | 2018-08-01 |
| 2018-08-02 | Oncopeptides AB | Fredrik Lehmann | Head of Research and CMC | Acquisition | 26 100 | 1 | SEK | 26 100 | 2018-08-01 |
| 2018-08-02 | Oncopeptides AB | Fredrik Lehmann | Head of Research and CMC | Disposal | 5 000 | 154,8 | SEK | 774 000 | 2018-08-01 |
| 2018-08-02 | Oncopeptides AB | Fredrik Lehmann | Head of Research and CMC | Disposal | 6 100 | 154,6 | SEK | 943 060 | 2018-08-01 |
| 2018-07-24 | Oncopeptides AB | Per Wold-Olsen | Chairman of the Board | Acquisition | 8 000 | 155,99 | SEK | 1 247 920 | 2018-07-22 |
| 2018-07-13 | Oncopeptides AB | Elisabet Augustsson | Head of regulatory affairs | Disposal | 1 000 | 200 | SEK | 200 000 | 2018-07-12 |
| 2018-05-30 | Oncopeptides AB | Per Wold-Olsen | Chairman of the Board | Acquisition | 602 | 113,8 | SEK | 68 507,6 | 2018-05-28 |
| 2018-05-30 | Oncopeptides AB | Per Wold-Olsen | Chairman of the Board | Acquisition | 4 507 | 114 | SEK | 513 798 | 2018-05-28 |
| 2018-05-30 | Oncopeptides AB | Per Wold-Olsen | Chairman of the Board | Acquisition | 917 | 113,6 | SEK | 104 171,2 | 2018-05-28 |
| 2018-05-22 | Oncopeptides AB | Per Wold-Olsen | Chairman of the Board | Acquisition | 406 | 104,8 | SEK | 42 548,8 | 2018-05-17 |
| 2018-05-22 | Oncopeptides AB | Per Wold-Olsen | Chairman of the Board | Acquisition | 250 | 104,6 | SEK | 26 150 | 2018-05-17 |
| 2018-05-22 | Oncopeptides AB | Per Wold-Olsen | Chairman of the Board | Acquisition | 1 500 | 105 | SEK | 157 500 | 2018-05-17 |
| 2018-05-22 | Oncopeptides AB | Per Wold-Olsen | Chairman of the Board | Acquisition | 1 000 | 104,4 | SEK | 104 400 | 2018-05-17 |
| 2018-05-22 | Oncopeptides AB | Per Wold-Olsen | Chairman of the Board | Acquisition | 2 | 104 | SEK | 208 | 2018-05-17 |
| 2018-05-22 | Oncopeptides AB | Per Wold-Olsen | Chairman of the Board | Acquisition | 650 | 104 | SEK | 67 600 | 2018-05-17 |
| 2018-05-22 | Oncopeptides AB | Per Wold-Olsen | Chairman of the Board | Acquisition | 433 | 104,4 | SEK | 45 205,2 | 2018-05-17 |
| 2018-05-22 | Oncopeptides AB | Per Wold-Olsen | Chairman of the Board | Acquisition | 200 | 103,8 | SEK | 20 760 | 2018-05-17 |
| 2018-05-22 | Oncopeptides AB | Per Wold-Olsen | Chairman of the Board | Acquisition | 325 | 104,8 | SEK | 34 060 | 2018-05-17 |
| 2017-07-14 | Oncopeptides AB | Fredrik Lehmann | Head of CMC | Acquisition | 1 000 | 63,68 | SEK | 63 680 | 2017-07-13 |